Technology
Our rabbit clonal antibodies are developed using a novel in-vitro cloning technology which enables the preparation of a pure immunoglobulin fraction corresponding to a single clone of B lymphocytes. The obtained immunoglobulin recognizes one single linear epitope on the antigen molecule, making this antibody comparable in quality to its monoclonal analogue.
Moreover, the influence of the protein tertiary structure – frequently present in epitopes recognized by monoclonal antibodies – is eliminated in immunoglobulins corresponding to the clonal antibody.
Advantages of rabbit clonal antibodies
- Exceptional specificity recognizing the corresponding antigen at the concentration of ≥5ng
- Highest possible sensitivity, affinity and avidity
- Reliability on any tissue
- Cost-effective dilutions
- Special focus on difficult targets
Please find more details about our technology in the following document: DB Biotech’s Monospecific Clonal Antibody Discovery Technology
Frequenty asked questions about technology process can be found in Support - FAQ.
Rabbit clonal antibodies - principle & design
